Table 5.
Monogenic dyslipidemias: clinical features
| Condition | Clinical features and comorbidities | Comments |
|---|---|---|
| Group 1: Monogenic hypercholesterolemia: severely elevated LDL-C | ||
| Familial hypercholesterolemia | Xanthomas: tendinous (mainly) rarely periosteal, intracranial, peripatellar, digital web spaces | HDL-C can be depressed; |
| Xanthelasmas, corneal arcus | Lp(a) can be very elevated; | |
| Early ASCVD: angina, acute coronary syndrome, myocardial infarction, stroke, transient ischemic attack, peripheral arterial disease, claudication, arterial bruits | Untreated biallelic (ie, homozygous) form can express clinical features in childhood while monoallelic (ie, heterozygous) form expresses clinical features in early adulthood | |
| Aortic valve disease | ||
| Autosomal recessive hypercholesterolemia | As above | Parents have normal lipids |
| Affected children are indistinguishable from homozygous FH | ||
| Sitosterolemia | Xanthomas: tendinous, cutaneous, tuberous | ↑ plasma beta-sitosterol, campesterol stigmasterol are diagnostic, as is positive genetic sequencing showing biallelic mutations |
| Splenomegaly | ||
| Early ASCVD: angina, myocardial infarction, stroke, transient ischemic attack, claudication, arterial bruits | ||
| Hemolysis/ hemolytic anemia | ||
| Impaired platelet aggregation with easy bruising or bleeding | ||
| Lysosomal acid lipase deficiency | Nausea, vomiting, diarrhea/steatorrhea | ↑ TG frequently |
| Protuberant abdomen | Transaminase elevations | |
| Hepatosplenomegaly, hepatic fibrosis, cirrhosis | Lipid infiltration of liver is cholesterol not TG | |
| Xanthomatous infiltration of adrenal, spleen, lymph nodes, bone marrow, small intestine, lungs, and thymus | Calcified adrenal gland on imaging | |
| Aliases: Wolman syndrome in infants and cholesterol ester storage disease (somewhat milder presentation) | ||
| Group 2: Monogenic hypocholesterolemia | ||
| Abetalipoproteinemia | Failure to thrive, steatorrhea | Acanthocytosis on peripheral blood smear |
| Night blindness, atypical retinitis pigmentosa, retinal degeneration | Complete absence of apo B containing lipoproteins; HDL-C normal | |
| Osteomalacia, osteoporosis | Undetectable levels of fat-soluble vitamins | |
| Ataxia, peripheral neuropathy, posterior column signs, deep tendon reflex loss | ||
| Hypobetalipoproteinemia | Biallelic (ie, homozygous) form is clinically identical to abetalipoproteinemia | Monoallelic (ie, heterozygous) form has mainly biochemical features (ie, low but not absent apo B-containing lipoproteins) plus susceptibility to fatty liver (typical hepatosteatosis) and protection from ACSCVD |
| Chylomicron retention (Anderson) disease | Similar to abetalipoproteinemia | Distinguished biochemically from abetalipoproteinemia and homozygous hypobetalipoproteinemia by normal TG levels |
| Systemic features are less severe; no erythrocyte abnormalities | ||
| Familial combined hypolipidemia | No defining clinical features | Biallelic form: profound deficiency of all lipoproteins |
| Probable protection from ASCVD | Monoallelic form: normal HDL-C; low apo B-containing lipoproteins | |
| Group 2A: Monogenic hyperalphalipoproteinemia: extremely elevated HDL-C | ||
| CETP deficiency | No defining clinical features | Biallelic form: extreme high HDL-C |
| Possible protection from ASCVD, although this is controversial | Monoallelic form: moderately elevated HDL-C | |
| Hepatic lipase deficiency | Associated with accelerated ASCVD | Increases in both HDL-C and apo B-containing lipoproteins; |
| Eruptive or palmar xanthomas sometimes | Managed according to LDL-C targets | |
| SR-B1 deficiency | No defining clinical features | Biallelic form: extremely high HDL-C |
| Possible protection from ASCVD, although this is controversial | Monoallelic form: moderately elevated HDL-C | |
| Group 2B: Monogenic hypoalphalipoproteinemia: severely depressed HDL-C | ||
| Apolipoprotein A-I deficiency (familial hypoalphalipoproteinemia) | Xanthomatosis: cutaneous, interdigital web spaces | Biallelic form: absent HDL-C and apo A-I |
| Predisposition to early ASCVD | Monoallelic form: moderately depressed HDL-C and apo A-I | |
| Tangier disease | Hepatosplenomegaly | Biallelic form: absent HDL-C and apo A-I with clinical features plus stomatocytes on peripheral blood film |
| Corneal opacities | Monoallelic form: moderately depressed HDL-C and apo A-I with no clinical features | |
| Enlarged orange tonsils | ||
| Dry/brittle skin/hair/nails | ||
| CE deposition in lymph nodes, bone marrow, liver, spleen, tonsils | ||
| Demyelinating sensory, autonomic, and motor neuropathies | ||
| Often premature coronary disease, angina, carotid bruits, claudication | ||
| Familial LCAT deficiency | Corneal lipid deposits and opacities | Low HDL-C, plasma esterified cholesterol, apo A-I and A-II |
| Foam cells in bone marrow and renal glomeruli | High plasma free cholesterol, TG, | |
| Proteinuria, renal failure | Alias: fish eye disease for severe LCAT deficiency | |
| Anemia | ||
| Group 3A: Monogenic hypertriglyceridemia: severely elevated TG | ||
| Familial chylomicronemia syndrome | Nausea, vomiting, failure to thrive, abdominal pain, pancreatitis risk | Biallelic form is associated with early onset (often childhood) |
| Lipemic plasma | Relatives with mono-allelic form express extremely heterogeneous phenotypes ranging from normal TG to severe HTG | |
| Hepatosplenomegaly, lipemia retinalis, eruptive xanthomas, jaundice | ||
| Infantile HTG, transient | Short stature | Elevated TG ± cholesterol and liver enzymes normalize with age |
| Hepatosplenomegaly | High urinary dicarboxylic acid | |
| Hepatic steatosis/fibrosis | ||
| Dysbetalipoproteinemia | Tuberoeruptive xanthomas, palmar crease xanthomas | Remnant lipoproteins, termed IDL and beta-VLDL, persist abnormally |
| Premature atherosclerosis | APOE E2/E2 homozygotes are predisposed but expression requires a second genetic abnormality | |
| Secondary dyslipidemias | ||
| Partial lipodystrophies | Distinctive patterns of regional lipoatrophy associated with simultaneous lipohypertrophy in unaffected areas | Elevated TG which can be severe in 10%-20% of cases |
| Insulin resistance | ||
| Recurrent pancreatitis | ||
| Generalized lipodystrophies | Absence of subcutaneous fat in subcutaneous tissues | Elevated TG, which can be severe in majority of cases |
| Insulin resistance | Elevated liver enzymes | |
| Recurrent pancreatitis | ||
| Hepatosplenomegaly |
Abbreviations: apo, apolipoprotein; ASCVD, atherosclerotic cardiovascular disease; CE, cholesterol ester; E2, binding defective isoform of apo E; FH, familial hypercholesterolemia; HDL-C, high-density lipoprotein cholesterol; HTG, hypertriglyceridemia; IDL, intermediate-density lipoprotein; LCAT, lecithin:cholesterol acyltransferase; LDL-C, low-density lipoprotein cholesterol; Lp(a), lipoprotein(a); TG, triglyceride; TTG, ; VLDL, very low-density lipoprotein.